Benchmarks and tools

Clinical trial budget negotiation checklist for sites

By TrialNotice · Updated
Two professionals negotiating across a glass table at dusk with city lights behind them
Short answerBefore signing a clinical trial budget, check twelve things: your own internal budget, a nonrefundable startup fee, realistic screen failure payment, priced prescreening, funded recruitment, your overhead rate, monthly payments, holdback at or below 10%, a complete invoiceables list, inflation adjustment, training and record retention costs, and defined payment triggers.

Your checks are saved in this browser, so you can return to the list during a negotiation.

Why these twelve?

  • Screen failures and recruitment are where sites lose the most: 88% say screen failures are not sufficiently covered (SCRS), and 53% self fund recruitment (SCRS).
  • Startup fee: SCRS describes it as covering costs incurred before enrollment (SCRS).
  • Holdback: the most common in 2023 was 10% to 14% (IntuitionLabs, citing SCRS); Penn caps it at 10% and adds at least 5% annual inflation for multi year studies (Penn Medicine).
  • Internal budget first: UNC's guidance starts with reading the protocol and estimating actual costs (UNC TraCS).

For the full approach, see how to negotiate a clinical trial budget. A funded recruitment line is what makes physician outreach a study cost rather than a site loss.

Get your study in front of the right local physicians

TrialNotice builds a physician referral pipeline around one active study. We identify relevant local physicians within driving distance of your site, send study aligned direct mail, follow up by email and LinkedIn, track engagement with recipient level QR codes, and route warm responses into your site team's workflow.

Talk to TrialNotice

Sources

  1. Society for Clinical Research Sites, Site Finances White Paper (2024)
  2. SCRS 2024 Global Site Landscape results, Site Solutions Summit
  3. Society for Clinical Research Sites, Site Resource for Invoiceables (2022)
  4. University of Pennsylvania Perelman School of Medicine, Budget Preparation and Development
  5. IntuitionLabs, "Clinical Trial Site Payment Benchmarks 2026" (citing the SCRS 2023 Site Landscape Survey)
  6. UNC TraCS, "An Introduction to Industry Clinical Trial Budget and Contract Negotiation"

Keep reading

Research site manager looking at a monitor showing an enrollment bar chart falling below a red target line
Benchmarks and tools

Clinical trial enrollment statistics: the complete reference

The verified numbers on site enrollment: how many sites miss targets, how enrollment concentrates, screen failure, dropout, activation, and protocol complexity. Every figure links to its original source.

 Hands sorting patient folders into green tabbed and amber tabbed stacks on an oak desk
Benchmarks and tools

Screen failure rates by therapeutic area: reference data

Published screen failure benchmarks: 36.3% across therapeutic areas, 57% in CNS, and 70 to 80% in MASH. Plus how to calculate your own rate and use it in budgets and forecasts.

 Clinical research coordinator welcoming the first study patient at a research clinic entrance
Benchmarks and tools

Site activation and study startup benchmarks

Tufts CSDD benchmarks for study startup: 31.4 weeks from site identification to startup completion, 9.9 weeks faster at repeat sites, and only 62% of North American sites activating.